PCIi033-A-6

IMRB-CFTR-Y122X

General

iPSC Line

hPSCreg name PCIi033-A-6
Cite as:
PCIi033-A-6
Alternative name(s)
IMRB-CFTR-Y122X
iPSC line type Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines No similar lines found.
Last update 9th March 2026
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Institut Mondor de Recherche Biomédicale (IMRB)
Owner Institut Mondor de Recherche Biomédicale (IMRB)
Distributors
Derivation country France

External iPSC Databases

BioSamples SAMEA120077266

General iPSC Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

iPSC Genetic Modification

Disease/phenotype related modifications
Synonyms
  • Cystic Fibrosis
  • cystic fibrosis
Genetic modifications
CFTR (target)
Isogenic modification
7q31.2
NM_000492.4(CFTR):c.366T>A (p.Tyr122Ter)
NP_000483.3:p.Tyr122Ter
Homozygous
Mutated

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.
Is the medical history available upon request? No
Is clinical information available? No

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA9699309

Ethics

Also have a look at the ethics information for the parental line PCIi033-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? Synthego and IDT
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? Yes
Constraints for use or distribution Phenocell. Distribution of the cell line can be done for academic use only

iPSC Derivation

General

The source cell information can be found in the parental cell line PCIi033-A.

Reprogramming method

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

iPSC Culture Conditions

Surface coating Vitronectin
Feeder cells
No
Passage method Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
O2 Concentration 95 %
CO2 Concentration 5 %
Medium mTeSR™ Plus
Has Rock inhibitor (Y27632) been used at passage previously with this iPSC line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this iPSC line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this iPSC line?
Yes

iPSC Characterisation

Analysis of undifferentiated iPSCs
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Oct4
Yes
SOX2
Yes
NANOG
Yes
TRA 1-81
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Marker Expressed
GATA4
Yes
SOX17
Yes
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Marker Expressed
CXCR4
Yes
Brachyury
Yes
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation
Marker Expressed
Nestin
Yes
Pax6
Yes

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (iPSC Line)

Has the iPSC line karyotype been analysed?
Yes
46,XY
Karyotyping method: mFISH

Other Genotyping (iPSC Line)

Is there genome-wide genotyping or functional data available?
Yes
SNP typing array